ADVATAB
Live / Registered — Registered and renewed (as of 24 Jul 2019)
What this means for you
Registered since 21 Jul 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Jul 2019).
Record
- Serial number
- 78252564
- Registration number
- 3659316
- Mark type
- Word mark
- Filed
- 21 May 2003
- Published for opposition
- 21 Jun 2005
- Registered
- 21 Jul 2009
- Next maintenance due
- 21 Jul 2019
- Attorney of record
- Shawn Duckworth
Goods and services
- Class 005 — Pharmaceuticals: Orally disintegrating pharmaceutical tablets for use in the treatment, namely, prevention and relief of, insomnia, congestion, cough, histamine production, headaches and allergies; orally disintegrating pharmaceutical tablets, namely, allergenics, antihistamines, sedatives, and decongestants
Owner
- ADARE PHARMACEUTICALS, INC., Philadelphia, PA, US
- APTALIS PHARMA LIMITED, BRAY, COUNTY WICKLOW, IE
- Eurand Pharmaceuticals, Ltd., Dublin, IE
- Eurand Pharmaceuticals, Ltd., Dublin, IE
- Eurand Pharmaceuticals, Ltd., Dublin, IE
Prosecution history
- 20 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Oct 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 24 Jul 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 24 Jul 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 24 Jul 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 24 Jul 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jun 2019 — TEAS SECTION 8 & 9 RECEIVED
- 21 Jul 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Sept 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Aug 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Aug 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.